Publications by authors named "Pankaj S Ghate"

T-lineage acute lymphoblastic leukaemia (T-ALL) is a high-risk tumour that has eluded comprehensive genomic characterization, which is partly due to the high frequency of noncoding genomic alterations that result in oncogene deregulation. Here we report an integrated analysis of genome and transcriptome sequencing of tumour and remission samples from more than 1,300 uniformly treated children with T-ALL, coupled with epigenomic and single-cell analyses of malignant and normal T cell precursors. This approach identified 15 subtypes with distinct genomic drivers, gene expression patterns, developmental states and outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • * The study found that 11% of patients who relapsed after InO developed mutations in the CD22 gene, which allowed cancer cells to evade treatment, often through losing or altering the CD22 protein's structure.
  • * Additional mutations were also seen in genes related to DNA damage response, raising concerns about how cancer cells adapt post-treatment, emphasizing the need for understanding these mechanisms to improve future therapies, especially before procedures like stem cell transplantation.
View Article and Find Full Text PDF
Article Synopsis
  • Inotuzumab ozogamicin (InO) is a targeted therapy for B-cell acute lymphoblastic leukemia that delivers a cytotoxic drug to cells expressing the CD22 antigen.
  • A study on patients treated with InO revealed that approximately 11% exhibited genomic mutations contributing to treatment resistance, with various escape mechanisms like protein truncation and destabilization.
  • The findings highlight the role of DNA damage repair processes in promoting CD22 mutations and suggest that understanding these genetic changes can help improve treatment strategies for overcoming resistance to therapy.
View Article and Find Full Text PDF

The bone marrow microenvironment (BME) drives drug resistance in acute lymphoblastic leukemia (ALL) through leukemic cell interactions with bone marrow (BM) niches, but the underlying mechanisms remain unclear. Here, we show that the interaction between ALL and mesenchymal stem cells (MSCs) through integrin β1 induces an epithelial-mesenchymal transition (EMT)-like program in MSC-adherent ALL cells, resulting in drug resistance and enhanced survival. Moreover, single-cell RNA sequencing analysis of ALL-MSC co-culture identifies a hybrid cluster of MSC-adherent ALL cells expressing both B-ALL and MSC signature genes, orchestrated by a WNT/β-catenin-mediated EMT-like program.

View Article and Find Full Text PDF

RAB3GAP1 is GTPase activating protein localized to the ER and Golgi compartments. In humans, mutations in RAB3GAP1 are the most common cause of Warburg Micro syndrome, a neurodevelopmental disorder associated with intellectual disability, microcephaly, and agenesis of the corpus callosum. We found that downregulation of RAB3GAP1 leads to a reduction in neurite outgrowth and complexity in human stem cell derived neurons.

View Article and Find Full Text PDF
Article Synopsis
  • Intrachromosomal amplification of chromosome 21 is a specific subtype of high-risk childhood acute lymphoblastic leukemia (iAMP21-ALL) that involves complex genetic changes on chromosome 21, contributing to its development.
  • A study of 124 iAMP21-ALL patients revealed distinct subgroups based on their genetic alterations and identified a common amplified region containing 71 genes, many of which are linked to leukemia.
  • The research also highlighted early genetic changes in the disease, illustrated clonal diversity, and emphasized the need for improved diagnostic methods to better manage iAMP21-ALL cases.
View Article and Find Full Text PDF

Advancing cure rates for high-risk acute lymphoblastic leukemia (ALL) has been limited by the lack of agents that effectively kill leukemic cells, sparing normal hematopoietic tissue. Molecular glues direct the ubiquitin ligase cellular machinery to target neosubstrates for protein degradation. We developed a novel cereblon modulator, SJ6986, that exhibits potent and selective degradation of GSPT1 and GSPT2 and cytotoxic activity against childhood cancer cell lines.

View Article and Find Full Text PDF

Autism spectrum disorders (ASD) are associated with defects in neuronal connectivity and are highly heritable. Genetic findings suggest that there is an overrepresentation of chromatin regulatory genes among the genes associated with ASD. ASH1 like histone lysine methyltransferase (ASH1L) was identified as a major risk factor for ASD.

View Article and Find Full Text PDF

Increased production, oligomerization and aggregation of amyloid-β (Aβ) peptides are hallmark pathologies of Alzheimer's disease (AD). Expressing familial AD mutations (amyloid precursor protein and/or presenilins mutations), the Aβ-pathologies of AD has been recapitulated in animal models of AD. Very few primary cell culture-based models of AD are available and they exhibit very weak Aβ-pathologies compared to what is seen in AD patients and animal models of AD.

View Article and Find Full Text PDF

Neuroblastoma is the most common cancer in infants and fourth most common cancer in children. Despite recent advances in cancer treatments, the prognosis of stage-IV neuroblastoma patients continues to be dismal which warrant new pharmacotherapy. A novel tetracyclic condensed quinoline compound, 8-methoxypyrimido [4',5':4,5]thieno(2,3-b) quinoline-4(3H)-one (MPTQ) is a structural analogue of an anticancer drug ellipticine and has been reported to posses anticancer property.

View Article and Find Full Text PDF

Background: Malaria is a tropical disease caused by protozoan parasite, Plasmodium, which is transmitted to humans by various species of female anopheline mosquitoes. Anopheles stephensi is one such major malaria vector in urban parts of the Indian subcontinent. Unlike Anopheles gambiae, an African malaria vector, transcriptome of A.

View Article and Find Full Text PDF